Archives: Contractor Email

Dear Colleague

Please find attached correspondence HERE from Prof. Sir. Michael McBride, Chief Medical Officer.

SUMMARY

• The Department’s Test and Trace Transition Plan, advice to the general population in relation to COVID-19 Test, Trace and Isolation has changed from 22 April 2022.
• In light of the changes to guidance for the population, the purpose of this letter is to provide updated guidance for Trust and independent sector healthcare providers on:
  • The management of health and social care workers (except those who work in care homes) who have COVID symptoms;
  • The management of health and social care workers who test positive for COVID-19;
  • The management of health and social care workers who are close contacts of COVID-19;
  • The use of asymptomatic testing with lateral flow tests for health and social care staff; and
  • The use of asymptomatic testing with lateral flow tests for visitors to hospitals and clinical settings.
  • The advice in this letter does not apply to care homes. Separate guidance for care homes will be issued by the Public Health Agency.

ACTION

• Contractors are asked to review the correspondence.
• Please do not hesitate to contact your local HSCB office or the CPNI office should you require any further information.

Kind regards

Dear Contractor

The Public Health Agency has oversight of the COVID-19 Vaccination programme in Northern Ireland and has requested that SPPG provide sufficient information to assure that all 477 RQIA registered Care Homes are paired with respective CPVS pharmacies to achieve the successful completion of the Spring COVID-19 Booster Campaign by end of May 2022.

The recent Update G12 outlined the request for the network of Moderna CPVS pharmacies to complete an e-form for each care home requiring to be vaccinated, on a weekly basis each Wednesday.

This is a REMINDER to submit an individual e-form for all of the Care Homes you have made arrangements with, to deliver vaccination clinics. Please complete e-form submissions TODAY.

From 21 April 2022, SPPG would ask that you complete the e-form as soon as you have made a pairing arrangement with a Care Home.

Please do not hesitate to contact CPNI should you require any further information.

Kind regards

Dear Colleague

Please find correspondence HERE from Kathryn Turner, Pharmacy Lead, Strategic Planning and Performance Group.

SUMMARY

• Evaluations for the last campaign, “Making Healthier Choices”, can now be submitted. This survey is available from 4 April 2022 and should have been completed by 2 May 2022. It can be accessed at HERE.
• It is vital that all pharmacies contracted to provide “Living Well” submit their evaluation survey after each campaign as it allows data to be collated to demonstrate the value and impact of the service to other sectors.
• Compliance will be monitored with the service requirements, in particular evaluation submission. Where failure has been identified to comply, such as failure to submit evaluation data, the right to recover all, or part of, this funding via an adjustment to the pharmacy’s BSO payment account is reserved.

ACTION

• Contractors are asked to review the correspondence.
• Submit evaluations for the last campaign, “Making Healthier Choices” as soon as possible. It can be accessed at HERE.
• Please do not hesitate to contact the CPNI office should you require any further information.

Kind regards

This update contains important information for community pharmacy teams, including details of the ongoing response to the COVID-19 pandemic.

BSO ALERTS 

• Weekly Drug Alerts are available here.
  • Sodium Bicarbonate 1.26% Solution for Infusion 28 April 2022
  • Paroxetine 40mg tablets 27 April 2022
• Weekly Shortages Information is available here.
• Serious Shortage Protocols are available here.

CPNI ALERTS 

• Final Concessionary Prices 29 April 2022
• Third Concessionary Prices 29 April 2022
• Pharmacy Collect NI Update 29 April 2022
• Community Pharmacy COVID-19 Vaccination Service Weekly Update 29 April 2022
• Recent Political Party Representatives Pharmacy Visits 28 April 2022
• Adherence Payment And Advance Repayment Update 28 April 2022
• REMINDER COVID-19 Spring Booster Programme Care Home eForm 27 April 2022

DOH(NI) ALERTS 

• Medicines Management Newsletter 29 April 2022
• Learning Matters Edition 20 29 April 2022
• PANORAMIC Study Update 29 April 2022
• COVID-CPVS Update 28 April 2022
• Pharmacy Collect NI Update 28 April 2022
• Update Asymptomatic COVID-19 Testing Arrangements for Care Home 22 April 2022

Please bring this to the attention of your pharmacy team(s).

Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.

Or report medicine shortages, pricing and staffing issues via the CPNI’s Medicine Shortage Reporter and Situation Reporter.

Kind regards

Dear Colleague

The final update of concessionary prices were granted for April 2022:

Drug	Pack Size	Concessionary Price
Bimatoprost 100micrograms/ml eye drops	3	£3.10
Celecoxib 100mg capsules	60	£7.22
Clonidine 25microgram tablets	112	£11.52
Dipyridamole 100mg tablets	84	£21.89
Exemestane 25mg tablets	30	£3.40
Fluoxetine 40mg capsules	30	£3.40
Lercanidipine 10mg tablets	28	£4.24
Losartan 100mg / Hydrochlorothiazide 25mg tablets	28	£11.66
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets	28	£5.62
Mometasone 0.1% cream	100	£10.94
Mometasone 0.1% cream	30	£3.28
Moxonidine 200microgram tablets	28	£6.63
Prasugrel 10mg tablets	28	£12.97
Rizatriptan 10mg tablets	3	£3.63
Solifenacin 5mg tablets	30	£3.54
Solifenacin 10mg tablets	30	£4.01
Sulfasalazine 500mg gastro-resistant tablets	112	£39.93
Sulfasalazine 500mg tablets	112	£33.96
Trimethoprim 50mg/5ml oral suspension sugar free	100	£9.48

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Concessionary prices may be granted up until the end of the month so CPNI will notify you of any further concessionary prices as and when they are agreed.

Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter. Concessionary prices are also published on the CPNI website.

Kind regards

Dear Colleague

The third update of concessionary prices were granted for April 2022:

Drug	Pack Size	Concessionary Price
Co-codamol 30mg/500mg effervescent tablets	32	£2.03
Co-codamol 30mg/500mg effervescent tablets	100	£6.34
Co-tenidone 100mg/25mg tablets	28	£1.42
Ibandronic Acid 50mg tablets	28	£145.99
Isotretinoin 20mg capsules	30	£16.02
Sulfasalazine 250mg/5ml oral suspension sugar free	500	£94.22
Tamoxifen 10mg/5ml oral solution sugar free	150	£74.52
Valsartan 160mg capsules	28	£7.08

Concessionary prices will be paid against the usual code, no additional endorsements are needed.

Concessionary prices may be granted up until the end of the month so CPNI will notify you of any further concessionary prices as and when they are agreed.

Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter. Concessionary prices are also published on the CPNI website.

Kind regards